Precigen Long Term Debt Current 2011-2026 | PGEN

Annual Long Term Debt Current Precigen

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
1.14 M	956 K	1.2 M	1.21 M	1.39 M	2.66 M	4.18 M	559 K	502 K	386 K	930 K	1.68 M	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
4.18 M	386 K	1.4 M

Long Term Debt Current of other stocks in the Biotechnology industry

Issuer	Long Term Debt Current	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	3.63 M	-	2.43 %	$ 254 M	Germany
Amphastar Pharmaceuticals AMPH	7.93 M	$ 21.94	2.48 %	$ 1.03 B	USA
I-Mab IMAB	8.06 M	-	-	$ 866 M	China
Aeglea BioTherapeutics AGLE	625 K	-	-	$ 1.01 B	USA
Aptorum Group Limited APM	433 K	$ 0.9	0.49 %	$ 6.62 M	China
ACADIA Pharmaceuticals ACAD	9.96 M	$ 22.66	3.19 %	$ 3.76 B	USA
Advaxis ADXS	166 K	-	-9.65 %	$ 45.9 M	USA
AIkido Pharma AIKI	554 K	-	1.93 %	$ 17.4 M	USA
Akouos AKUS	671 K	-	0.23 %	$ 488 M	USA
Allakos ALLK	3.25 M	-	-	$ 28.6 M	USA
AlloVir ALVR	316 K	-	4.14 %	$ 49.1 M	USA
Ampio Pharmaceuticals AMPE	274 K	-	-11.43 %	$ 502 K	USA
Applied Molecular Transport AMTI	4.64 M	-	-	$ 10.1 M	USA
Aeterna Zentaris AEZS	215 K	-	5.93 %	$ 314 M	Canada
Brainstorm Cell Therapeutics BCLI	208 K	-	-2.5 %	$ 5.88 M	USA
Applied Therapeutics APLT	429 K	-	-	$ 8.42 M	USA
Aptinyx APTX	337 K	-	-39.0 %	$ 4.57 M	USA
AgeX Therapeutics AGE	181 K	-	-10.17 %	$ 12.2 K	USA
Aravive ARAV	2.2 M	-	-13.39 %	$ 1.45 M	USA
Aridis Pharmaceuticals ARDS	538 K	-	17.91 %	$ 11.1 M	USA
BioNTech SE BNTX	45 M	$ 102.75	-2.57 %	$ 27.2 B	Germany
Applied Genetic Technologies Corporation AGTC	1.27 M	-	-	$ 26.5 M	USA
Aquestive Therapeutics AQST	631 K	$ 4.14	1.35 %	$ 443 M	USA
Arcutis Biotherapeutics ARQT	294 K	$ 23.58	1.38 %	$ 3 B	USA
Ayala Pharmaceuticals AYLA	419 K	-	-	$ 7.46 M	Israel
Autolus Therapeutics plc AUTL	4.56 M	$ 1.44	-0.35 %	$ 383 M	Britain
Aptose Biosciences APTO	193 K	-	-45.71 %	$ 1.2 M	Canada
AstraZeneca PLC AZN	382 M	-	-	$ 96.9 B	Britain
AVROBIO AVRO	878 K	-	1083.1 %	$ 745 M	USA
Can-Fite BioPharma Ltd. CANF	43 K	$ 2.92	-0.45 %	$ 4.81 M	Israel
BeiGene, Ltd. BGNE	20.7 M	-	0.49 %	$ 251 B	Cayman-islands
CureVac N.V. CVAC	3.47 M	-	-	$ 867 M	Germany
bluebird bio BLUE	21.2 M	-	-	$ 546 M	USA
ContraFect Corporation CFRX	671 K	-	-5.16 %	$ 5.39 M	USA
Cardiff Oncology CRDF	730 K	$ 1.72	-	$ 115 M	USA
BioXcel Therapeutics BTAI	65 K	$ 1.1	3.77 %	$ 13.4 M	USA
Cabaletta Bio CABA	3.46 M	$ 2.99	1.19 %	$ 300 M	USA
Cara Therapeutics CARA	116 K	-	-3.03 %	$ 260 M	USA
Allena Pharmaceuticals ALNA	317 K	-	3.16 %	$ 1.9 M	USA
CASI Pharmaceuticals CASI	1.06 M	-	-	$ 35.4 M	USA
CymaBay Therapeutics CBAY	7 K	-	-	$ 3.45 B	USA